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Since the first recognized outbreaks of human
Ebola virus hemorrhagic fever in Africa in the
1970s, biological and genetic differences have been
described among the four distinct Ebola viruses
isolated: Zaire, Sudan, and Côte d’Ivoire, all iso-
lated from humans,  and Reston virus isolated from
macaque monkeys from the Philippines (1-5).
Serologic evidence has suggested the presence
of Ebola virus in Gabon since 1982 (6).  Since late
1994, three apparently independent outbreaks of
Ebola virus hemorrhagic fever have occurred
among humans in northeastern Gabon, in the
forested areas of equatorial Ogooué-Ivindo province.
The first, which started in December 1994 in gold-
panner encampments of far northeastern Gabon,
in the Minkouka area (between 1°24' and 1°44'
North and 12°49' and 12°59' East, Figure 1) near
the Nouna River, had several laboratory-con-
firmed cases (7).  The second, which began in early
February 1996 in Mayibout village (1°07' North,
13°06' East, Figure 1) on the Ivindo River, resulted
in 37 Ebola hemorrhagic fever cases (8).  The only
means of transportation between these two areas
is by boat; Makokou, the closest town to them
(0°33' North, 12°50' East, Figure 1), has the
provincial hospital to which patients and contacts
were transferred. The third outbreak, which is
ongoing, started in July 1996 in the village of
Booué (0°06' South, 11°57' East, Figure 1), where
most of the cases occurred; however, scattered
cases have been diagnosed in surrounding
villages and towns.  Some patients have even
been transported to Libreville, probably during the
incubation period of the disease. One patient was
treated in South Africa, where a fatal noso-
comial infection was subsequently reported in a
health care worker (9,10); 43 deaths due to Ebola
hemorrhagic fever have already been reported
during this prolonged outbreak (11).
We report here the Ebola virus glycoprotein
(GP) gene sequences obtained from human sam-
ples collected during each of the three Gabonese
epidemics.  The Gab280 sequence comes from blood
collected 1 day before the death of  a patient, from
the Nouna area, during the 1994 outbreak.  The
Gab282 and Gab283 sequences were derived
from blood collected during the spring 1996
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Three outbreaks of Ebola hemorrhagic fever have recently occurred in Gabon.
Virus has been isolated from clinical materials from all three outbreaks, and nucleotide
sequence analysis of the glycoprotein gene of the isolates and virus present in clinical
samples has been carried out. These data indicate that each of the three outbreaks
should be considered an independent emergence of a different Ebola virus of the Zaire
subtype.  As in earlier Ebola virus outbreaks, no genetic variability was detected
between virus samples taken during an individual outbreak.
Figure 1. Geographic distribution of the three Ebola
virus hemorrhagic fever epidemics and site of the
infected chimpanzee in Gabon.
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outbreak, from two primary patients who were
infected while butchering a chimpanzee they found
dead in the forest. The Gab281 sequence was
derived from blood collected from what appears
to have been  a secondary case during the same
outbreak; the patient was  probably infected by con-
tact with one of the index patients while visiting
a traditional doctor (nganga) who lived near
Mayibout village. Sequences Gab275 to Gab279
were derived from blood specimens collected from
two patients during the fall 1996 outbreak:
Gab275, Gab276, and Gab277 sequences are from
one patient (a serum specimen collected on
October 27, a primary tissue culture passage from
that specimen, and a primary tissue culture pas-
sage from another blood sample drawn on
October 25, respectively). The Gab278 and Gab279
sequences were derived from plasma  (collected
during the acute phase of illness) from another
patient and its primary tissue culture passage,
respectively. The isolation of Ebola virus in Vero
E6 cell culture from human blood samples
collected during the three different outbreaks
was easily accomplished in a single passage.
RNA was extracted from blood or primary
tissue culture samples (Table 1) by using a com-
mercial kit (RNaid Kit , BIO 101, Inc., Vista, CA)
as directed by the instruction manual. Viral
sequences were amplified from RNA by using the
reverse transcriptase-polymerase chain reaction
(RT-PCR) technique, and DNA products were
Initially, a 783-base-pair fragment of the GP
gene, which encompasses the most variable region
of the gene, was sequenced. A consensus sequence
was established by aligning all the Ebola from
Gabon, the Zaire 1976 and 1995 Ebola virus
sequences, as well as the sequence of the virus
obtained from a nurse in South Africa who was
infected by a patient from Gabon in November
1996 (10). Viruses from the same outbreak had
identical sequences, but unique virus sequences
were found in each of the three different out-
breaks in Gabon. Although the viruses causing
the Gabonese outbreaks clearly belong to the
Zaire subtype, they were distinct from viruses
that had caused disease in Zaire. No differences
were observed between tissue-culture-passaged
and clinical-material-derived sequences or between
primary or secondary case sequences. RNA
extracted from a single representative of each
outbreak (sequences Gab277, Gab280, and Gab283)
was then used to generate the entire GP gene
sequence for the Gabon Ebola viruses. The GP
from the Gabon spring 1996 viruses differed from
the sequence of the Gabon fall 1994 viruses by
four nucleotides. The GP sequence from the
Gabon fall 1996 viruses differed from the
sequence of the Gabon spring 1996 virus by four
additional nucleotides (Figure 2).
Maximum parsimony analyses were performed
by using the entire coding regions of the GP genes
of the Gabon viruses, together with those of
Table 1. Origin and identification of the sequence used in the analysis
Date of
Outbreak Patient Specimen original Laboratory
# specimen #
Gabon, Fall 94 1 Blood Dec 28,94 Gab280
Gabon, 1 Blood Feb 20,96 Gab281
 Spring 96 2 Blood Feb 8,96 Gab282
3 Blood Feb 8,96 Gab283
Gabon, 1 Serum Oct 27,96 Gab275
 Fall 96 Vero E6
 Passage 1 Oct 27,96 Gab276
Vero E6
 Passage 1 Oct 25,96 Gab277
2 Plasma Oct 27,96 Gab278
Vero E6
 Passage 1 Oct 27,96 Gab279
South Africa, 1 Vero E6
 Fall 96 Passage 1 Nov 9,96 SA253
sequenced as described elsewhere (5).
Briefly, amplified products were
subjected to agarose electrophoresis
and were stained and visualized with
ethidium bromide; DNA bands were
then excised and extracted by using
the QIAEX II kit (QIAGEN, Inc.,
Chatsworth, CA).  In some cases,
nested PCR with internal primers
was performed, using first-round
products. Amplified products were
directly sequenced by using an
automated nonisotopic method (ABI
PRISM dye-terminator cycle sequenc-
ing kit, Perkin-Elmer, Foster City,
CA). Centri Sep columns (Princeton
Separation, Inc.) were used to remove
excess dye-labeled dideoxynucleotide
terminators, and reaction products
were analyzed on an ABI 377 or 373
DNA sequencer (Perkin-Elmer).61 Vol. 3, No. 1—January-March 1997 Emerging Infectious Diseases
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previously characterized Ebola viruses (5). In
addition, the sequence of a 1980 Marburg virus
isolate (Musoke strain) was included to provide
an outgroup in the analysis.  The Phylogenetic
Analysis Using Parsimony version 3.1.1 software,
using the branch-and-bound search option (12),
was run on a Power Macintosh 8100/110 (Apple
Computer, Inc.). A 4:1 transversion:transition
weighting was used in analyses. A single most
parsimonious tree was obtained (Figure 2), and
bootstrap analysis strongly supports a common
evolutionary origin for the viruses associated
with disease in Gabon and Zaire. Overall, these
data indicate that the three Gabon outbreaks
should be considered independent events, likely
originating from different sources.
During a 20-month period, Gabon has had
three different outbreaks of Ebola virus hemor-
rhagic fever. The first and the second episodes
apparently started during the rainy season
(December and February), while the third began
during the dry season (July). The deaths of non-
human primates were associated with all three
outbreaks. Minkouka area inhabitants reported
finding dead chimpanzees and gorillas in the forest
during the fall of 1994. All the primary human
patients in the spring 1996 outbreak were infected
while butchering dead chimpanzees. For the third
outbreak, the investigation has indicated an
index patient who was a  hunter, living in a forest
camp in the Booué area.  During the same period,
an Ebola virus-infected dead chimpanzee was
found in the forest (0°11’ South, 11°36' East) near
Booué; Ebola virus infection in the chimpanzee was
confirmed using a newly developed immuno-
histochemical Ebola skin biopsy test (Figure 3).
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Figure 2. Phylogenetic tree showing the relationship
between the Ebola viruses that caused outbreaks of disease
in Gabon and previously described filoviruses (5).  The entire
coding region for the glycoprotein gene of the viruses shown
was used in maximum parsimony analysis, and a single
most parsimonious tree was obtained. Numbers in
parentheses indicate bootstrap confidence values for branch
points and were generated from 500 replicates (heuristic
search).  Branch length values are also shown.
Figure 3. Immunostaining of Ebola virus antigens (red)
within vascular endothelial cells in skin biopsy of the
chimpanzee found dead in the forest near Booué.  Note
also the presence of extracellular viral antigens. (Rabbit
anti-Ebola virus serum, napthol/fast red with hematoxy-
lin counterstain, original magnification x250).
The presence of stable virus sequences and
the lack of genetic variability between strains
isolated within an outbreak was previously seen
during the outbreak of Ebola hemorrhagic fever
in Kikwit, Zaire, in 1995 (Rodriguez et al.,
unpublished data), and despite the small number
of isolates tested, is again suggested in Gabon.62 Emerging Infectious Diseases Vol. 3, No. 1—January-March 1997
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A long term surveillance for Ebola virus using
this test is under way in Africa (13,14).
In Côte d’Ivoire in 1994, an investigator was
infected with Ebola virus while performing
necropsy on a dead chimpanzee (15).  Primates
are unlikely to be the reservoir of Ebola virus since
experimental or natural infection is quickly fatal.
A better knowledge of the ecology of great apes,
particularly their food preferences and habitats,
may lead to the identification of the virus reservoir.
Gabon’s equatorial forests, where three independent
outbreaks have occurred in less than 2 years, offer
an excellent opportunity for these investigations.
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